Pharmacokinetic Study of TAS-118 Compared with S-1

Trial Profile

Pharmacokinetic Study of TAS-118 Compared with S-1

Phase of Trial: Phase I

Latest Information Update: 24 May 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur/folinic acid (Primary) ; Gimeracil/oteracil/tegafur
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Sponsors Taiho Pharmaceutical
  • Most Recent Events

    • 20 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top